Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis by Bridel, C, van Wieringen, WN, Zetterberg, H, Tijms, BM, Teunissen, CE, Gray, E, Turner, M

Factors influencing resilience to postoperative delirium in adults undergoing elective orthopaedic surgery by Bowman, EML, Cardwell, C, McAuley, DF, McGuinness, B, Passmore, AP, Beverland, D, Zetterberg, H, Schott, JM, Cunningham, EL

PET tau and amyloid-β burden in mild Alzheimer's disease: divergent relationship with age, cognition and cerebrospinal fluid biomarkers by Koychev, I, Gunn, R, Firouzian, A, Lawson, J, Zamboni, G, Ridha, B, Sahakian, B, Rowe, J, Howard, R, Zetterberg, H, Mackay, C, Lovestone, S

Aβ42/Aβ40 and Aβ42/Aβ38 ratios are associated with measures of gait variability and activities of daily living in mild Alzheimer's disease: a pilot study by Koychev, I, Galna, B, Zetterberg, H, Lawson, J, Zamboni, G, Ridha, BH, Rowe, J, Thomas, A, Howard, R, Malhotra, P, Ritchie, C, Lovestone, S, Rochester, L

Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes by Jabbari, E, Woodside, J, Guo, T, Magdalinou, N, Chelban, V, Athauda, D, Lees, A, Foltynie, T, Houlden, H, Church, A, Hu, M, Rowe, J, Zetterberg, H, Morris, H

BRain health and healthy AgeINg in retired rugby union players, the BRAIN Study: study protocol for an observational study in the UK by Gallo, V, McElvenny, D, Hobbs, C, Davoren, D, Morris, H, Crutch, S, Zetterberg, H, Fox, N, Kemp, S, Cross, M, Arden, N, Davies, M, Malaspina, A, Pearce, N

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation by Teunissen, C, Otto, M, Engelborghs, S, Herukka, S, Lehmann, S, Lewczuk, P, Lleó, A, Perret-Liaudet, A, Tumani, H, Turner, M, Verbeek, M, Wiltfang, J, Zetterberg, H, Parnetti, L, Blennow, K

Peripherin is a biomarker of axonal damage in peripheral nervous system disease by Keddie, S, Smyth, D, Keh, RYS, Chou, MKL, Grant, D, Surana, S, Heslegrave, A, Zetterberg, H, Wieske, L, Michael, M, Eftimov, F, Bellanti, R, Rinaldi, S, Hart, MS, Petzold, A, Lunn, MP

Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults by Koychev, I, Adler, AI, Edison, P, Tom, B, Milton, JE, Butchart, J, Hampshire, A, Marshall, C, Coulthard, E, Zetterberg, H, Hellyer, P, Cormack, F, Underwood, BR, Mummery, CJ, Holman, RR

HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection by Bodda, C, Reinert, LS, Fruhwürth, S, Richardo, T, Sun, C, Zhang, B-C, Kalamvoki, M, Pohlmann, A, Mogensen, TH, Bergström, P, Agholme, L, O'Hare, P, Sodeik, B, Gyrd-Hansen, M, Zetterberg, H, Paludan, SR

Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy by Lombardi, V, Querin, G, Ziff, O, Zampedri, L, Martinelli, I, Heller, C, Foiani, M, Bertolin, C, Lu, C, Malik, B, Allen, K, Rinaldi, C, Zetterberg, H, Heslegrave, A, Greensmith, L, Hanna, M, Soraru, G, Malaspina, A, Fratta, P

Gait in mild Alzheimer’s disease: feasibility of multi-centre measurement in the clinic and home with body-worn sensors: a pilot study by Mc Ardle, R, Morris, R, Hickey, A, Del Din, S, Koychev, I, Gunn, RN, Lawson, J, Zamboni, G, Ridha, B, Sahakian, BJ, Rowe, JB, Thomas, A, Zetterberg, H, MacKay, C, Lovestone, S, Rochester, L, Deep and Frequent Phenotyping study team

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease by Ashton, NJ, Nevado-Holgado, AJ, Barber, IS, Lynham, S, Gupta, V, Chatterjee, P, Goozee, K, Hone, E, Pedrini, S, Blennow, K, Schöll, M, Zetterberg, H, Ellis, KA, Bush, AI, Rowe, CC, Villemagne, VL, Ames, D, Masters, CL, Aarsland, D, Powell, J, Lovestone, S, Martins, R, Hye, A

Synaptic protein CSF levels relate to memory scores in individuals without dementia by Wesenhagen, KEJ, de Leeuw, DM, Tomassen, J, Gobom, J, Bos, I, Vos, SJB, Martinez-Lage, P, Tainta, M, Popp, J, Peyratout, G, Tsolaki, M, Vandenberghe, R, Freund-Levi, Y, Verhey, F, Lovestone, S, Streffer, J, Dobricic, V, Blennow, K, Scheltens, P, Smit, AB, Bertram, L, Teunissen, CE, Zetterberg, H, Tijms, BM

Advancing specificity in delirium: the delirium subtyping initiative by Bowman, EML, Brummel, NE, Caplan, GA, Cunningham, C, Evered, LA, Fiest, KM, Girard, TD, Jackson, TA, LaHue, SC, Lindroth, HL, Maclullich, AMJ, McAuley, DF, Oh, ES, Oldham, MA, Page, VJ, Pandharipande, PP, Potter, KM, Sinha, P, Slooter, AJC, Sweeney, AM, Tieges, Z, Van Dellen, E, Wilcox, ME, Zetterberg, H, Cunningham, EL

A multi-center study of neurofilament assay reliability and inter-laboratory variability by Gray, E, Oeckl, P, Amador, MDM, Andreasson, U, An, J, Blennow, K, Bowser, R, De Schaepdryver, M, Heslegrave, A, Kuhle, J, Maceski, A, Koel-Simmelink, M, Lamari, F, Lombardi, V, Malaspina, A, Nilsson, I, Poesen, K, Salachas, F, Steinacker, P, Teunissen, CE, Van Damme, P, Zetterberg, H, Ludolph, A, Jeromin, A, Turner, MR, Otto, M

Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators by Moseby-Knappe, M, Levin, H, Blennow, K, Ullén, S, Zetterberg, H, Lilja, G, Dankiewicz, J, Jakobsen, JC, Lagebrant, A, Friberg, H, Nichol, A, Ainschough, K, Eastwood, GM, Wise, MP, Thomas, M, Keeble, T, Cariou, A, Leithner, C, Rylander, C, Düring, J, Bělohlávek, J, Grejs, A, Borgquist, O, Undén, J, Simon, M, Rolny, V, Piehler, A, Cronberg, T, Nielsen, N

Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP by Wiseman, F, Pulford, L, Barkus, C, Liao, F, Portelius, E, Webb, R, Chávez-Gutiérrez, L, Cleverley, K, Noy, S, Sheppard, O, Collins, T, Powell, C, Sarell, C, Rickman, M, Choong, X, Tosh, J, Siganporia, C, Whittaker, H, Stewart, F, Szaruga, M, London Down Syndrome Consortium, Murphy, M, Blennow, K, De Strooper, B, Zetterberg, H, Bannerman, D, Holtzman, D, Tybulewicz, V, Fisher, E, LonDownS Consortium

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury by Taquet, M, Skorniewska, Z, Zetterberg, H, Geddes, JR, Mummery, CJ, Chalmers, JD, Ho, L-P, Horsley, A, Marks, M, Poinasamy, K, Raman, B, Leavy, OC, Richardson, M, Elneima, O, McAuley, HJC, Shikotra, A, Singapuri, A, Sereno, M, Saunders, RM, Harris, VC, Houchen-Wolloff, L, Mansoori, P, Greening, NJ, Harrison, EM, Docherty, AB, Lone, NI, Quint, J, Greenhalf, W, Wain, LV, Brightling, CE, Evans, RE, Harrison, PJ, Koychev, I

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study by ten Kate, M, Redolfi, A, Peira, E, Bos, I, Vos, S, Vandenberghe, R, Gabel, S, Schaeverbeke, J, Scheltens, P, Blin, O, Richardson, J, Bordet, B, Wallin, A, Eckerstrom, C, Molinuevo, J, Engelborghs, S, Van Broeckhoven, C, Martinez-Lage, P, Popp, J, Tsolaki, M, Verhey, F, Tsolaki, M, Baird, A, Legido-Quigley, C, Bertram, L, Dobricic, V, Zetterberg, H, Lovestone, S, Streffer, J, Bianchetti, S, Novak, G, Revillard, J, Gordon, M, Xie, Z, Wottschel, V, Frisoni, G, Visser, P, Barkhof, F